InsiderTrades

Form 4 for PLSE PULSE BIOSCIENCES, INC.

Accepted 2026-02-17 00:00:00 ET · period of report 2026-02-12 · accession 0001437749-26-004438 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2026-02-17 2026-02-12+ PLSE Danahy Kevin Patrick Chief Commercial Off M - OptEx $1.53 +60.0K 63.3K +1,819% +$91.8K
DM 2026-02-17 2026-02-12+ PLSE Danahy Kevin Patrick Chief Commercial Off S - Sale+OE $23.51 -60.0K 43.3K -58% -$1.41M
DM 2026-02-17 2026-02-12+ PLSE Danahy Kevin Patrick Chief Commercial Off M - OptEx $0.00 -60.0K 345.0K -15% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-02-17 M A 20,000 $1.53 63,298 D — —
2 Common Common Stock 2026-02-17 S D 20,000 $23.63 43,298 D — — (F4) The price in column 4 is the weighted average price per share sold. The price per share actually received by the reporting person ranged from $22.98 to $24.99 per share. For all transactions reported in this Form 4 using a weighted average price, the reporting person undertakes upon request by the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the range.
3 Common Common Stock 2026-02-12 S D 20,000 $23.37 43,298 D — — (F2) The price in column 4 is the weighted average price per share sold. The price per share actually received by the reporting person ranged from $22.81 to $26.00 per share. For all transactions reported in this Form 4 using a weighted average price, the reporting person undertakes upon request by the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the range.
4 Common Common Stock 2026-02-13 M A 20,000 $1.53 63,298 D — —
5 Common Common Stock 2026-02-13 S D 20,000 $23.53 43,298 D — — (F3) The price in column 4 is the weighted average price per share sold. The price per share actually received by the reporting person ranged from $23.00 to $25.00 per share. For all transactions reported in this Form 4 using a weighted average price, the reporting person undertakes upon request by the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the range.
6 Common Common Stock 2026-02-12 M A 20,000 $1.53 63,298 D — —
7 Derivative Stock Option (right to buy) 2026-02-17 M D 20,000 $0.00 305,000 D $1.53 · — to 2032-09-23 20,000 Common Stock (F5) Options granted on September 23, 2022, to acquire up to 450,000 shares of Common Stock, in connection with reporting person's promotion, with 25% vesting on each anniversary of grant, pursuant to the terms of an amendment to reporting person's Employment Agreement dated February 9, 2022.
8 Derivative Stock Option (right to buy) 2026-02-13 M D 20,000 $0.00 325,000 D $1.53 · — to 2032-09-23 20,000 Common Stock (F5) Options granted on September 23, 2022, to acquire up to 450,000 shares of Common Stock, in connection with reporting person's promotion, with 25% vesting on each anniversary of grant, pursuant to the terms of an amendment to reporting person's Employment Agreement dated February 9, 2022.
9 Derivative Stock Option (right to buy) 2026-02-12 M D 20,000 $0.00 345,000 D $1.53 · — to 2032-09-23 20,000 Common Stock (F5) Options granted on September 23, 2022, to acquire up to 450,000 shares of Common Stock, in connection with reporting person's promotion, with 25% vesting on each anniversary of grant, pursuant to the terms of an amendment to reporting person's Employment Agreement dated February 9, 2022.